Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PTGX | PRAX | PCVX | ||
| Company | Protagonist Therapeutics Inc | Praxis Precision Medicines Inc | Vaxcyte Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 125.89 | 319.82 | 56.56 | ||
| High | 131.87 | 329.27 | 58.49 | ||
| Low | 125.24 | 310.10 | 55.62 | ||
| Latest | 131.62 | 318.52 | 58.39 | ||
| Change | +6.45 | -1.08 | +2.31 | ||
| % Change | +5.15% | -0.34% | +4.12% | ||
| Volume | 708,300 | 358,300 | 1,378,600 | ||
| 20-Day Average Volume | 864,655 | 676,260 | 1,967,115 | ||
| Previous Close | 125.17 | 319.60 | 56.08 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 113.92 | 287.42 | 51.45 | ||
| 20-Day Raw Stochastic | 99.30% | 69.11% | 92.22% | ||
| 20-Day Relative Strength | 73.39 | 52.70 | 61.93 | ||
| Weighted Alpha | +137.62 | +122.27 | +63.98 | ||
| Today's Opinion | 100% Buy | 56% Buy | 40% Buy | ||
| Previous Opinion | 100% Buy | 56% Buy | 40% Buy | ||
| Last Month's Opinion | 24% Buy | 32% Buy | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.33% since 06/25/26 | -2.85% since 06/25/26 | +8.77% since 06/25/26 | ||
| Low | 118.27 on 06/29/26 | 310.10 on 07/02/26 | 53.64 on 06/26/26 | ||
| High | 131.87 on 07/02/26 | 354.17 on 06/29/26 | 59.49 on 06/30/26 | ||
| 1-Month | |||||
| %Chg | +41.18% since 06/02/26 | +23.42% since 06/02/26 | +23.16% since 06/02/26 | ||
| Low | 93.00 on 06/03/26 | 238.77 on 06/10/26 | 45.30 on 06/11/26 | ||
| High | 131.87 on 07/02/26 | 354.17 on 06/29/26 | 59.49 on 06/30/26 | ||
| 3-Month | |||||
| %Chg | +26.83% since 04/02/26 | +2.62% since 04/02/26 | +0.02% since 04/02/26 | ||
| Low | 92.75 on 06/02/26 | 238.77 on 06/10/26 | 45.30 on 06/11/26 | ||
| High | 131.87 on 07/02/26 | 366.52 on 05/27/26 | 63.31 on 04/17/26 | ||
| 6-Month | |||||
| %Chg | +50.97% since 01/02/26 | +11.22% since 01/02/26 | +25.68% since 01/02/26 | ||
| Low | 77.00 on 02/23/26 | 238.77 on 06/10/26 | 43.94 on 01/05/26 | ||
| High | 131.87 on 07/02/26 | 366.52 on 05/27/26 | 65.00 on 02/25/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,464,612 | 8,880,016 | 8,431,399 | ||
| Shares Outstanding, K | 64,311 | 27,879 | 144,398 | ||
| Annual Sales | 46,020,000 | 0 | 0 | ||
| Annual Net Income | -130,150,000 | -303,270,000 | -766,630,000 | ||
| Last Quarter Sales | 56,370,000 | 0 | 0 | ||
| Last Quarter Net Income | 3,780,000 | -92,560,000 | -320,620,000 | ||
| 60-Month Beta | 1.79 | 2.74 | 1.22 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.05 on 05/05/26 | -3.20 on 05/07/26 | -2.30 on 05/06/26 | ||
| Earnings Date | 08/05/26 | 08/03/26 | 08/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||